
CRL
Charles River Laboratories
$182.07
$0.09 (-0.05%)
Selasa, 02 Juni 2026 08:00 WIB
$182.16
$1.47 (0.81%)
Senin, 01 Juni 2026 19:59 WIB
8.7 B
Market Cap
Harga kembali 1 minggu16.33%
Harga kembali 1 Bulan9.89%
Harga kembali 3 Bulan1.99%
Harga kembali 6 Bulan4.20%
Harga Tertinggi (52 Minggu)228.24
Harga Terendah (52 Minggu)132.64
Latar Belakang Perusahaan
Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory, gene therapy and cell therapy services for the Pharmaceutical, Medical device and Biotechnology industries. It also supplies assorted biomedical products and outsourcing services for research and development in the pharmaceutical industry and offer support in the fields of basic research, drug discovery, safety and efficacy, clinical support, and manufacturing.
Summary
Valuation Information
Current PE Ratio (TTM)-49.23
Forward PE Ratio16.23
Current Price to Book Value2.98
Current Price to Sales2.22
EV to Revenue2.87
EV to EBITDA39.82
PEG Ratio2.84
Per Share
Current EPS (Annualized)-3.7
Diluted EPS (TTM)-3.7
Revenue Per Share81.96
Current Book Value Per Share61.05
Dividend
Dividend Per Share-
Dividend Yield-
Ex Dividend Date-
Dividend Payment Date-
Income Statement
EBITDA889624000
Profit Margin-0.0459
Operating Margin0.159
Feed
Berita
Broker Summary
Technical
Finansial
Laporan
Profil

23 Juli 2025, 02:47 WIB